Rob Armstrong

Rob Armstrong is a seasoned board member and executive with extensive experience in the biopharmaceutical industry. Notable roles include Chief Business Officer at Gelesis, Chairman of the Board of Directors at Curza and Retromer Therapeutics, and current President and Chief Executive Officer at Artax Biopharma Inc. Academic contributions were made as Associate and Assistant Professor in the Department of Chemistry and Biochemistry at the University of California, Los Angeles. Previous experience also includes significant leadership positions at Amgen and Eli Lilly and Company, where Armstrong spearheaded initiatives in small molecule drug discovery and global external R&D. Educational credentials include a B.S. from UC San Diego, a Ph.D. from Colorado State University, and a NIH Postdoctoral Fellowship at Harvard University.